Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0001209191-23-056446

SVP, Chief Business Officer sold 3,287 shares at $9.69 ($31,851)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Davis Andrew SVP, Chief Business Officer 2023-11-20 Sale −3,287 $9.69 $31,851 217,374 D
Open-market sales · 3,287 sh · avg $9.69 · $31,851
Loading xslF345X05/doc4.xml…